Lianhe Aigen Pharmatech Co., Ltd., a wholly-owned subsidiary of Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., Ltd.), is committed to providing one-stop CRDMO services including new drug discovery, preclinical, clinical and commercial stages for the world's leading innovative pharmaceutical companies, empowering global innovative drugs and contributing to human health.